Pharmaceutical raw material in the form of cannabis, other than industrial hemp, and in the form of extracts, pharmaceutical tinctures, and all other types of extracts made from cannabis other than industrial hemp and resin of cannabis plants other than industrial hemp used for the manufacture of magistral formulae

Draft act amending the act on counteracting drug addiction and the act on the reimbursement of drugs, foods for particular nutritional uses and medical devices

The notification concerns regulations regarding the manufacture of a pharmaceutical raw material in the form of cannabis other than industrial hemp and in the form of extracts, pharmaceutical tinctures, and all other types of extracts made from cannabis other than industrial hemp and resin of cannabis plants other than industrial hemp used for the manufacture of magistral formulae and the active substance used for the manufacture of this raw material.